Evidence map›Paper›PMID 42298554›Full record

ArticleJournal of nanobiotechnology2026

Potassium-scavenging train-style nanorobots potentiate radiotherapy and reverse immunosuppression in glioblastoma.

Peng Liu, Rudong Chen, Xue Yuan, Yijing Zhang, Xintong Li, Baoli Zhou, Xin Xu, Mengbin Ding, Wen Zhang, Xiaoyuan Ji

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Peng Liu *Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Rudong Chen *Department of Orthopedics, Shandong Provincial Hospital, Shandong First Medical University, Jinan, 250021, Shandong, China.
Xue YuanAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China.
Yijing ZhangAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China.
Xintong LiAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China.
Baoli ZhouAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China.
Xin XuAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China.
Mengbin DingAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China. 1023235033@tju.edu.cn.
Wen ZhangDepartment of Orthopedics, Shandong Provincial Hospital, Shandong First Medical University, Jinan, 250021, Shandong, China. zhangwen2789@sdfmu.edu.cn.
Xiaoyuan JiAcademy of Medical Engineering and Translational Medicine, Medical College, Tianjin University, Tianjin, 300072, China. jixiaoyuan@tju.edu.cn.

Funding

National Natural Science Foundation of China 32471388
6 · The paper itself

Abstract

Radiotherapy (RT) is essential for glioblastoma treatment but is compromised by two key challenges: hypoxic radio-resistance and the post-radiotherapy leakage of intracellular potassium ions (K

Indexed as

GlioblastomaPotassiumAnimalsApoptosisCell Line, TumorGoldHumansImmunosuppression TherapyMiceRadiation-Sensitizing AgentsSilicon DioxideT-LymphocytesTumor MicroenvironmentGoldPotassiumRadiation-Sensitizing AgentsSilicon DioxideGlioblastomaImmunosuppression microenvironmentNanorobotsPotassium ionsRadiotherapy

Identifiers

PMID42298554
PMCPMC13501849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.